Sept 20 (Reuters) - Regeneron Pharmaceuticals Inc
and Israeli drugmaker Teva Pharmaceutical Industries
on Tuesday said they would co-develop Regeneron's experimental
new type of pain drug and together market the medicine if it
succeeds in trials and is approved.
Read more
No comments:
Post a Comment